For Novartis' Generic Advair, Another 18 Months Was Too Far Into The Unknown

 
• By Derrick Gingery
  
Neon Light Sign Lungs Icon
Novartis gave up in its attempt to become the second generic Advair to reach the US market. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Generics

More from Biosimilars & Generics